UAE Pharmaceuticals Market: Dynamics, Key Players, and Industry Projections till 2028 by TechSci Research

the UAE Pharmaceuticals Market was valued at USD 4009.31 million in 2022. It is anticipated to grow at a steady rate of 7.96% during the forecast period from 2018 to 2028
Comunicato Precedente

next
Comunicato Successivo

next

Market Overview

According to the TechSci Research report titled "UAE Pharmaceuticals Market - By Region, Forecast and Opportunities, 2018-2028", the UAE Pharmaceuticals Market was valued at USD 4009.31 million in 2022. It is anticipated to grow at a steady rate of 7.96% during the forecast period from 2018 to 2028. This growth is driven by an increase in the incidence of chronic diseases, proactive government initiatives, and recent developments in the pharmaceutical sector.

 

Key Drivers of Market Growth

Rise in Prevalence of Chronic Diseases

The UAE is experiencing a significant rise in chronic diseases, including cardiovascular diseases, cancer, neurological disorders, and lifestyle diseases. These conditions are the primary factors influencing the growth of the pharmaceutical market in the country. Health experts report that at least 50 percent of heart attack patients in the UAE are under the age of 50, largely due to obesity and sedentary lifestyles. Additionally, data from the Global Cancer Observatory in 2020 indicates approximately 4807 new cancer cases in the UAE, highlighting the growing demand for effective treatments and medications.

 

Browse over 21 market data Figures spread through 70 Pages and an in-depth TOC on "UAE Pharmaceuticals Market.”

 

Government Initiatives

The UAE government is actively fostering technological advancements in the pharmaceutical industry. Key initiatives such as the Dubai Industrial Strategy 2030 and Abu Dhabi Vision 2030 aim to develop the pharmaceutical sector due to its significant growth prospects, export potential, and economic impact. The government is also implementing favorable schemes and plans to enhance distribution channels and funding strategic locations with sophisticated logistics infrastructure.

 

Educational Initiatives and Public Health Management

In January 2022, the UAE’s Ministry of Health and Prevention (MoHAP) launched the educational initiative "STEPS" (Development and Training for Excellence in Clinical Pharmacy System). This initiative is designed to improve clinical pharmacy practices across the country, further propelling the pharmaceutical market's growth. Additionally, the National Unified Medical Record system and the Public Health Management platform aim to use digital health solutions to foster collaboration between the public and private sectors while enhancing public health initiatives.

 

Recent Trends in the UAE Pharmaceuticals Market

Increased Manufacturing and Strategic Alliances

In recent years, the UAE has seen a shift towards increased local manufacturing of pharmaceutical products. Market players are strengthening bonds with multinational companies to meet domestic demand and reduce reliance on imported drugs. This trend is supported by government initiatives that provide favorable conditions for pharmaceutical manufacturing and distribution.

 

Digital Health Integration

The integration of digital health solutions is becoming increasingly prevalent in the UAE’s healthcare sector. The adoption of technologies such as telemedicine, electronic health records, and mobile health applications is enhancing patient care and streamlining pharmaceutical services. These advancements are expected to further boost the growth of the pharmaceutical market in the UAE.

 

Drivers of Market Growth

  1. Government Funding and Support: The UAE government provides substantial funds for the development of drugs and therapies for various diseases, supporting research and development activities.
  2. Technological Advancements: Continuous advancements in drug manufacturing technologies and digital health solutions are enhancing the efficiency and effectiveness of pharmaceutical products.
  3. Healthcare Infrastructure: Significant investments in healthcare infrastructure, including the construction of new hospitals and clinics, are improving healthcare access and quality, driving pharmaceutical demand.
  4. Medical Tourism: The UAE is becoming a popular destination for medical tourism due to its high-quality healthcare services and advanced medical facilities, further boosting the pharmaceutical market.

 

Challenges in the UAE Pharmaceuticals Market

Despite the positive growth prospects, the UAE pharmaceuticals market faces significant challenges. One of the biggest challenges is the strict regulations on the import and distribution of pharmaceutical products. All pharmaceutical products must undergo rigorous testing and obtain approvals from the Ministry of Health and Prevention (MoHAP) before they can be sold in the UAE. This process can be lengthy and complicated, leading to delays in the launch of new products.

 

Competitive Analysis

The UAE Pharmaceuticals Market is highly competitive, with several major companies operating in the sector. Key players include:

  • Pfizer UAE
  • Johnson & Johnson Middle-East
  • GlaxoSmithKline & Neopharma
  • Julphar Gulf Pharmaceutical Industries
  • Roche Pharmaceuticals Middle East FZCO
  • Niner Pharmaceuticals LLC
  • Lifepharma FZE
  • Hikma Pharmaceuticals

These companies are focusing on strategic alliances, mergers and acquisitions, and extensive research and development activities to strengthen their market position and expand their product portfolios.

 

Download Free Sample Report

 

Market Segmentation

The UAE Pharmaceuticals Market can be segmented based on drug type, product type, application, distribution channel, and region.

By Drug Type

  • Generic Drugs: The generic drugs segment dominated the market in 2022, with a market share of 69.76%. The lower cost of generic drugs compared to branded drugs, due to the absence of the need for animal and clinical (human) studies to demonstrate safety and effectiveness, drives this segment's growth.
  • Branded Drugs

By Product Type

  • Over-the-Counter (OTC) Drugs: The OTC drugs segment held a market share of 69.74% in 2022. The ease of availability and cost-effectiveness of OTC drugs are key factors contributing to this segment's dominance.
  • Prescription Drugs

By Application

  • Cardiovascular: The cardiovascular segment is expected to dominate the market with a share of 28.91% during the forecast period due to the rise in heart failure and heart diseases.
  • Oncology
  • Metabolic Disorders
  • Musculoskeletal
  • Anti-infective
  • Others

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-Pharmacy

 

By Region

The market is further segmented by region, analyzing the growth potential and trends across different areas of the UAE.

 

Benefits of the Research Report

The TechSci Research report on the UAE Pharmaceuticals Market offers numerous benefits:

  1. Comprehensive Market Analysis: Provides detailed insights into the market size, structure, and growth potential.
  2. Identification of Key Trends: Highlights emerging trends and opportunities in the UAE pharmaceuticals market.
  3. Strategic Planning: Aids in strategic planning and investment decisions for market players and investors.
  4. Competitive Landscape: Analyzes the competitive landscape, profiling major companies and their strategies.
  5. Market Segmentation: Offers a detailed segmentation of the market based on drug type, product type, application, distribution channel, and region.
  6. Regulatory Insights: Provides an overview of the regulatory framework governing the pharmaceutical market in the UAE.
  7. Market Drivers and Challenges: Identifies key drivers and challenges impacting market growth.


Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

Read Blog- The Growing Diagnostics Lab Market in India: An In-Depth Analysis

 

Recently Published Report –

 

Vitamin & Mineral Premixes Market

Potato Protein Market

Functional Proteins Market

 

Contact

US -

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]

Web: https://www.techsciresearch.com/

Per maggiori informazioni
Allegati
Slide ShowSlide Show
Non disponibili
;